WO2005000241A3 - Compositons and methods for topical administration - Google Patents

Compositons and methods for topical administration Download PDF

Info

Publication number
WO2005000241A3
WO2005000241A3 PCT/US2004/020037 US2004020037W WO2005000241A3 WO 2005000241 A3 WO2005000241 A3 WO 2005000241A3 US 2004020037 W US2004020037 W US 2004020037W WO 2005000241 A3 WO2005000241 A3 WO 2005000241A3
Authority
WO
WIPO (PCT)
Prior art keywords
methods
compositons
topical administration
vanishing cream
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2004/020037
Other languages
French (fr)
Other versions
WO2005000241A2 (en
WO2005000241A8 (en
Inventor
Chunfeng Guo
Thomas Chan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Macrochem Corp
Original Assignee
Macrochem Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Macrochem Corp filed Critical Macrochem Corp
Priority to AU2004251731A priority Critical patent/AU2004251731A1/en
Priority to EP04776927A priority patent/EP1663142A2/en
Priority to US10/562,113 priority patent/US20070190019A1/en
Priority to NZ544851A priority patent/NZ544851A/en
Publication of WO2005000241A2 publication Critical patent/WO2005000241A2/en
Publication of WO2005000241A3 publication Critical patent/WO2005000241A3/en
Anticipated expiration legal-status Critical
Publication of WO2005000241A8 publication Critical patent/WO2005000241A8/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • A61K8/8158—Homopolymers or copolymers of amides or imides, e.g. (meth) acrylamide; Compositions of derivatives of such polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Medicinal Preparation (AREA)

Abstract

Vanishing cream base compositions and vanishing cream compositions suitable for topical application of an active agent to an animal or plant comprising water, at least one alcohol, a polymeric thickening agent, a skin penetration enhancing compound, and an emulsifying agent are provided. Methods for the use and manufacture of such creams are also disclosed.
PCT/US2004/020037 2003-06-23 2004-06-23 Compositons and methods for topical administration Ceased WO2005000241A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
AU2004251731A AU2004251731A1 (en) 2003-06-23 2004-06-23 Compositons and methods for topical administration
EP04776927A EP1663142A2 (en) 2003-06-23 2004-06-23 Compositons and methods for topical administration
US10/562,113 US20070190019A1 (en) 2003-06-23 2004-06-23 Compositions and methods for topical administration
NZ544851A NZ544851A (en) 2003-06-23 2004-06-23 A vanishing cream base composition suitable for topical administration of an active agent to an animal or plant

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48023003P 2003-06-23 2003-06-23
US60/480,230 2003-06-23

Publications (3)

Publication Number Publication Date
WO2005000241A2 WO2005000241A2 (en) 2005-01-06
WO2005000241A3 true WO2005000241A3 (en) 2005-11-17
WO2005000241A8 WO2005000241A8 (en) 2007-02-15

Family

ID=33551911

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2004/020037 Ceased WO2005000241A2 (en) 2003-06-23 2004-06-23 Compositons and methods for topical administration

Country Status (5)

Country Link
US (1) US20070190019A1 (en)
EP (1) EP1663142A2 (en)
AU (1) AU2004251731A1 (en)
NZ (1) NZ544851A (en)
WO (1) WO2005000241A2 (en)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006050002A2 (en) * 2004-10-28 2006-05-11 Idexx Laboratories, Inc. Compositions for controlled delivery of pharmaceutically active compounds
US8114440B2 (en) 2005-11-16 2012-02-14 Idexx Laboratories Inc. Pharmaceutical compositions for the administration of aptamers
US7754679B2 (en) 2005-11-16 2010-07-13 Idexx Laboratories, Inc. Pharmaceutical compositions for the administration of aptamers
FR2898498B1 (en) * 2006-03-15 2008-11-28 Galderma Sa NOVEL TOPIC COMPOSITIONS IN THE FORM OF O / W EMULSION COMPRISING PRO-PENETRANT GLYCOL
FR2898499B1 (en) * 2006-03-15 2008-11-28 Galderma Sa NOVEL TOPIC COMPOSITIONS IN THE FORM OF O / W EMULSION COMPRISING PRO-PENETRANT GLYCOL
WO2008067054A2 (en) 2006-10-12 2008-06-05 Topaz Pharmaceuticals Llc Topical avermectin formulations and methods for elimination and prophylaxis of susceptible and treatment-resistant strains of head lice
WO2008093412A1 (en) * 2007-01-31 2008-08-07 Cosmed Pharmaceutical Co., Ltd. Apparatus for measuring diffusion of transdermal absorption preparation
US20090017120A1 (en) * 2007-03-23 2009-01-15 Humco Holding Group, Inc. Phase stable lecithin organogel composition
EP2155190A4 (en) * 2007-05-04 2010-12-08 Topaz Pharmaceuticals Inc Topical formulations and methods for elimination and prophylaxis of susceptible and treatment resistant strains of head lice with multiple modes of action
US8828960B2 (en) 2007-07-17 2014-09-09 Idexx Laboratories, Inc. Amino acid vitamin ester compositions for controlled delivery of pharmaceutically active compounds
US20110052738A1 (en) * 2008-01-17 2011-03-03 Gary Dean Bennett Topical pain formulation
FR2928545B1 (en) * 2008-03-17 2013-08-02 Oreal USE OF MONOAMINE OXIDASE INHIBITORS FOR CAPILLARY PIGMENTATION
DE102008034388A1 (en) * 2008-07-23 2010-01-28 Henkel Ag & Co. Kgaa Surfactant-containing composition with special emulsifier mixture
JP5833007B2 (en) 2009-08-31 2015-12-16 ドクター・レディーズ・ラボラトリーズ・リミテッド Topical preparations containing steroids
NZ603091A (en) * 2010-05-04 2014-10-31 Nexmed Holdings Inc Therapeutic peptide composition and method
AU2011249043B2 (en) 2010-05-04 2015-07-09 Nexmed Holdings, Inc. Compositions of small molecule therapeutics
WO2012097160A1 (en) * 2011-01-14 2012-07-19 Nexmed Holdings, Inc. Rectal delivery method for therapeutic peptides
US20160066563A1 (en) * 2012-06-07 2016-03-10 David Moscatello Compositions and methods for collecting, washing, cryopreserving, recovering and return of lipoaspirates to physician for autologous adipose transfer procedures
PL2922528T3 (en) 2012-11-20 2017-12-29 Allergan, Inc. Topical dapsone and dapsone/adapalene compositions and methods for use thereof
US8785426B1 (en) 2013-12-13 2014-07-22 Upsher-Smith Laboratories, Inc. Testosterone gel compositions and related methods
US20160184431A1 (en) 2014-03-11 2016-06-30 Promius Pharma Llc Topical compositions comprising a corticosteroid
US11147799B2 (en) * 2016-12-06 2021-10-19 Jan Marius Keppel Hesselink Topical pharmaceutical composition containing phenytoin and a (co-) analgesic for the treatment of chronic pain
SG11202002105WA (en) 2017-09-11 2020-04-29 Atossa Therapeutics Inc Methods for making and using endoxifen
MX2020002683A (en) * 2017-09-11 2020-09-25 Atossa Therapeutics Inc Topical compositions and methods for treatment.
US20190083386A1 (en) * 2017-09-15 2019-03-21 Ampersand Biopharmaceuticals, Inc. Methods and formulations for transdermal administration of buffering agents
PL239074B1 (en) * 2019-06-16 2021-11-02 Univ Karola W Pradze Composition improving the penetration of biologically active substances through the surfaces of plant organs
JP7662204B2 (en) 2019-07-03 2025-04-15 アトッサ・セラピューティクス・インコーポレイテッド Sustained release compositions of endoxifen
US20240423959A1 (en) * 2022-06-21 2024-12-26 Jjr&D, Llc Topical benzimidazole formulations and methods for use in treating inflammatory dermatoses

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USH1480H (en) * 1993-12-09 1995-09-05 The Procter & Gamble Company Methods of using dyphylline for the promotion of hair growth
US6316428B1 (en) * 1995-03-10 2001-11-13 Wilson Trafton Crandall Topical moisturizing composition and method
US20030129150A1 (en) * 2000-02-25 2003-07-10 Gilles Pauly Cosmetic preparations containing plant extracts
US20030133891A1 (en) * 2000-03-23 2003-07-17 Claudia Panzer Deodorizing preparations containing nanosacle chitosans and/or chitosan derivatives

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU223343B1 (en) * 1991-05-20 2004-06-28 Novartis Ag. Compositions comprising allylamine derivatives, and process for their preparation
AU2002341984B2 (en) * 2001-10-04 2008-01-03 Macrochem Corporation Ibuprofen salt emulsifiers and cream formulations containing same
DE10163242A1 (en) * 2001-12-21 2003-07-10 Clariant Gmbh Deodorants and antiperspirants
US20040234628A1 (en) * 2003-05-22 2004-11-25 Kearns Marcy L. Topical composition for the treatment of skin disorders and methods of using the same

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USH1480H (en) * 1993-12-09 1995-09-05 The Procter & Gamble Company Methods of using dyphylline for the promotion of hair growth
US6316428B1 (en) * 1995-03-10 2001-11-13 Wilson Trafton Crandall Topical moisturizing composition and method
US20030129150A1 (en) * 2000-02-25 2003-07-10 Gilles Pauly Cosmetic preparations containing plant extracts
US20030133891A1 (en) * 2000-03-23 2003-07-17 Claudia Panzer Deodorizing preparations containing nanosacle chitosans and/or chitosan derivatives

Also Published As

Publication number Publication date
EP1663142A2 (en) 2006-06-07
WO2005000241A2 (en) 2005-01-06
US20070190019A1 (en) 2007-08-16
AU2004251731A1 (en) 2005-01-06
NZ544851A (en) 2008-03-28
WO2005000241A8 (en) 2007-02-15

Similar Documents

Publication Publication Date Title
WO2005000241A8 (en) Compositons and methods for topical administration
WO2005018574A3 (en) Immunostimulatory combinations and treatments
WO2008009379A3 (en) Active ingredient combinations having insecticide and acaricide properties
WO2004010952A3 (en) Methods and compositions for treatment of dermal conditions
WO2007029187A3 (en) Use of protoberberines as an active substance regulating the pilosebaceous unit
WO2005018530A3 (en) Penetrating pharmaceutical foam
WO2004064769A3 (en) Methods for making and using topical delivery agents
CA2567575A1 (en) Organo-gel formulations for therapeutic applications
EP1570840A3 (en) Topical composition comprising n-acetylaldosamines or n-acetylamino acids
ATE415817T1 (en) AGROCHEMICAL FORMULATIONS
WO2005009352A3 (en) Antimicrobial compositons containing synergistic combinations of quaternary ammonium compounds and essential oils and/or constituents thereof
EP1247456A3 (en) Palatable pharmaceutical compositions for companion animals
WO2011123623A3 (en) Skin, nail and hair topical antimicrobial methods using formulations containing organosilane quaternaries
WO2002019981A3 (en) Cosmetic and pharmaceutical composition comprising chelating/sequestering agents and their cosmetic and dermatological use
WO2006060515A3 (en) System for improved percutaneous absorption of skin benefiting agents
WO2004108075A3 (en) Self-warming or self-heating cosmetic and dermatological compositions and method of use
EP1561457A3 (en) Cosmetic compositions with long lasting skin moisturizing properties
EP1192938A3 (en) Composition to enhance permeation of topical skin agents
WO2004089329A3 (en) Topical compositions comprising n-acetylamino acids or related n-acetyl compounds
WO2004075867A3 (en) Preparations containing an extract of eperua falcata and/or constituents of the latter
WO2001051028A3 (en) Formulations and methods for administration of pharmacologically or biologically active compounds
WO2004058282A3 (en) Method of obtaining a soothing active ingredient, active ingredient and compositions obtained
UA88516C2 (en) Preparation of an active substance for protecting plants
WO2007082864A3 (en) Use of chavicol as an antiseptic
WO2007050369A3 (en) Topical pain relief compositions of n,2,3-trimethyl-2-isopropylbutamide and methods for using the same

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2004776927

Country of ref document: EP

Ref document number: 2004251731

Country of ref document: AU

Ref document number: 423/DELNP/2006

Country of ref document: IN

WWE Wipo information: entry into national phase

Ref document number: 544851

Country of ref document: NZ

ENP Entry into the national phase

Ref document number: 2004251731

Country of ref document: AU

Date of ref document: 20040623

Kind code of ref document: A

WWP Wipo information: published in national office

Ref document number: 2004776927

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 10562113

Country of ref document: US

Ref document number: 2007190019

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 10562113

Country of ref document: US